Acasti Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Acasti Pharma and buy or sell other stocks, ETFs, and their options commission-free!About ACST
Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil.
CEOJanelle D'Alvise
CEOJanelle D'Alvise
Employees—
Employees—
HeadquartersLaval, Québec
HeadquartersLaval, Québec
Founded2002
Founded2002
Employees—
Employees—
ACST Key Statistics
Market cap552.64M
Market cap552.64M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume6.42M
Average volume6.42M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.22
52 Week high$1.22
52 Week low$0.171
52 Week low$0.171
Stock Snapshot
As of today, Acasti Pharma(ACST) shares are valued at $2.37. The company's market cap stands at 552.64M.
On 2025-11-12, Acasti Pharma(ACST) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Acasti Pharma(ACST) stock has reached 0, versus its average volume of 6.42M.
Over the past 52 weeks, Acasti Pharma(ACST) stock has traded between a high of $1.22 and a low of $0.17.
Over the past 52 weeks, Acasti Pharma(ACST) stock has traded between a high of $1.22 and a low of $0.17.
People also own
Based on the portfolios of people who own ACST. This list is generated using Robinhood data, and it’s not a recommendation.